Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Fetal Outcome Using Third Trimester Modified Biophysical Profile Scan Compared to Standard of Care; an Open Label Randomized Controlled Trial at St. Francis Hospital Nsambya.

NCT03729089 is registered in ClinicalTrials.gov with Dr Andrew Odur as lead sponsor.

NCT NCT03729089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03729089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Fetal Outcome Using Third Trimester Modified Biophysical Profile Scan Compared to Standard of Care; an Open Label Randomized Controlled Trial at St. Francis Hospital Nsambya.
Lead sponsor
Dr Andrew Odur
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
March 29, 2019
Enrollment
198 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perinatal death, third trimester modified biophysical profile scan